Loading...
Interactions of Alginate-Deferoxamine Conjugates With Blood Components and Their Antioxidation in the Hemoglobin Oxidation Model
While deferoxamine (DFO) has long been used as an FDA-approved iron chelator, its proangiogenesis ability attracts increasing number of research interests. To address its drawbacks such as short plasma half-life and toxicity, polymeric conjugated strategy has been proposed and shown superiority. Owi...
Na minha lista:
| Udgivet i: | Front Bioeng Biotechnol |
|---|---|
| Main Authors: | , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Frontiers Media S.A.
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7026261/ https://ncbi.nlm.nih.gov/pubmed/32117933 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fbioe.2020.00053 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|